Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 603 24 664.8 |
96 | EP file number | EAKZ | 03 71 3632.2 |
86 | WO file number | WAKZ | PCT/US03/05500 |
97 | EP publication number | EPN | 1478738 |
87 | WO publication number | WPN | 2003072766 |
54 | Designation/title | TI | ANTI-CCR5 ANTIKÖRPER |
51 | IPC main class | ICM (ICMV) | C12N 5/06 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07K 16/28 (2006.01), A61K 39/395 (2006.01), C12N 15/13 (2006.01) |
22 | DE application date | DAT | Feb 21, 2003 |
96 | EP application date | EAT | Feb 21, 2003 |
86 | WO application date | WAT | Feb 21, 2003 |
43 | Date of first publication | OT | Sep 4, 2003 |
| Date of publication of grant | PET | Nov 12, 2008 |
71/73 | Applicant/owner | INH | AbbVie Biotherapeutics Inc. (n.d.Ges.d.Staates Delaware), Redwood City, Calif., US; CytoDyn, Inc., Lake Oswego, Oreg., US |
72 | Inventor | IN | OLSON, William, C., Ossining, NY 10562, US; MADDON, Paul. J., Scarsdale, NY 10583, US; VASQUEZ, Maximiliano, Palo Alto, CA 94303, US; HINTON, Paul, R., Sunnyvale, CA 94085, US; TSURUSHITA, Naoya, Palo Alto, CA 94306, US |
74 | Representative | VTR | WITTHOFF JAEKEL STEINECKE Patentanwälte PartG mbB, 52428 Jülich, DE |
| Address for service | | WITTHOFF JAEKEL STEINECKE Patentanwälte PartG mbB, 52428 Jülich, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 81128 Feb 22, 2002
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, SE, SI, SK, TR |
81 | Designated WO countries | WDS | LT, AL, LV, MK, RO |
| Published EP/WO documents | EPWOPN | Original document: EP000001478738 Searchable text:
EP000001478738 Original document:
EP000001478738B1 Searchable text:
EP000001478738B1 Original document:
WO002003072766 Searchable text:
WO002003072766 |
43 | Date of first publication | EVT | Sep 4, 2003 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Feb 23, 2023 (Show all update days)(Hide all update days)- Feb 23, 2023; Mar 9, 2022; Jan 25, 2022; Mar 5, 2021; Mar 12, 2020; Jan 15, 2020; Dec 10, 2019; Aug 13, 2019; Mar 13, 2019; Mar 9, 2019; Oct 26, 2018; Mar 8, 2018; Mar 9, 2017; Mar 11, 2016; Aug 25, 2015; Mar 13, 2015; Mar 11, 2015; Mar 18, 2014; Mar 8, 2014; Oct 24, 2013; Sep 25, 2013; Sep 5, 2013; Sep 3, 2013; Aug 2, 2013; Jun 20, 2013; Jun 13, 2013; May 28, 2013; Apr 23, 2013; Mar 27, 2013; Mar 16, 2013; Mar 12, 2013; Feb 27, 2013; Feb 26, 2013; Feb 21, 2013; Feb 15, 2013; Feb 2, 2013; Feb 1, 2013; Jan 30, 2013; Jan 27, 2013
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Oct 16, 2008 |
| Issue number | HN | 24 |
| Year | PJ | 2013 |
| Publication date | VT | Jun 13, 2013 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 2 |
71/73 | Applicant/owner | INH | PDL BioPharma, Inc., 94063 Redwood City, Calif., US; Progenics Pharmaceuticals, Inc., Tarrytown, N.Y., US |
71/73 | Previous applicant/owner | INHF | Progenics Pharmaceuticals, Inc., Tarrytown, N.Y., US, Protein Design Labs, Inc., Fremont, Calif., US |
View procedures New applicant/owner details (No.: 10)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Apr 19, 2013 |
| Issue number | HN | 24 |
| Year | PJ | 2013 |
| Publication date | VT | Jun 13, 2013 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 2 |
71/73 | Applicant/owner | INH | CytoDyn, Inc., Lake Oswego, Oreg., US; PDL BioPharma, Inc., 94063 Redwood City, Calif., US |
71/73 | Previous applicant/owner | INHF | PDL BioPharma, Inc., 94063 Redwood City, Calif., US, Progenics Pharmaceuticals, Inc., Tarrytown, N.Y., US |
View procedures New applicant/owner details (No.: 11)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Sep 4, 2013 |
| Issue number | HN | 43 |
| Year | PJ | 2013 |
| Publication date | VT | Oct 24, 2013 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 2 |
71/73 | Applicant/owner | INH | AbbVie Biotherapeutics Inc. (n.d.Ges.d.Staates Delaware), Redwood City, Calif., US; CytoDyn, Inc., Lake Oswego, Oreg., US |
71/73 | Previous applicant/owner | INHF | CytoDyn, Inc., Lake Oswego, Oreg., US, PDL BioPharma, Inc., 94063 Redwood City, Calif., US |